Valuation
- Market cap
- 51,552,000
- Revenue TTM
- $11,340,000
- Net income TTM
- $-101,920,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -898.77%
- Debt to equity
- 0.70
Trading
- Volume
- 68,500
- Avg volume
- 313,182
- Day's range
- $1.32 – $1.36
- Shares out
- 38,761,000
- Stochastic %K
- 23%
- Beta
- 1.65
- Analysts
- Sell
- Price target
- $3.75
Company profile
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 32 1 045 90 75
- Website
- https://www.nyxoah.com
- Address
- Rue Edouard Belin 12, Mont-Saint-Guibert, Belgium
Latest news
No headlines yet.
